Seaport Therapeutics
PrivateLast Round
IPO
Apr 10, 2026
Est. Valuation
$733M
Total Funding Raised
$325M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Seaport Therapeutics is a biopharmaceutical company focused on developing innovative neuropsychiatric medicines that address significant patient needs while providing oral bioavailability to minimize side effects and enhance patient quality of life.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seaport Therapeutics Comparables
Compare Seaport Therapeutics with similar companies based on industry and business-model similarity.
Seaport Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Apr 10, 2026 | ||||
| Series B | Oct 21, 2024 | ||||
| Series A | Apr 9, 2024 |
Key People
Founding team and executive leadership
Seaport Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CPP Investments | Series B |
| Invus Opportunities | Series B |
| ARCH Venture Partners | Series B, Series A |
| Foresite Capital | Series B |
| T. Rowe Price | Series B |
| Goldman Sachs Group, Inc. | IPO |
| PureTech Health | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
$100M raised in IPO round.
- Mar 26, 2026
New oral drug delivery technology developed with Monash University.
Seaport Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Seaport Therapeutics's valuation, stock price, and market status.